Global Burosumab Production, Demand and Key Producers, 2022-2028

December 2022 | 76 pages | ID: GFE0877949DFEN
GlobalInfoResearch

Abstracts

Burosumab , a fully human IgG1 monoclonal antibody directed at fibroblast growth factor 23 (FGF23), is indicated for the treatment of X-linked hypophosphatemia (XLH), a condition associated with excessive FGF23 production.

This report studies the global Burosumab production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Burosumab, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Burosumab that contribute to its increasing demand across many markets.

The global Burosumab market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).

Highlights and key features of the study

Global Burosumab total production and demand, 2017-2028, (K Units)

Global Burosumab total production value, 2017-2028, (USD Million)

Global Burosumab production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)

Global Burosumab consumption by region & country, CAGR, 2017-2028 & (K Units)

U.S. VS China: Burosumab domestic production, consumption, key domestic manufacturers and share

Global Burosumab production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)

Global Burosumab production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)

Global Burosumab production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)

This reports profiles key players in the global Burosumab market based on the following parameters – headquarters, production locations, products portfolio, Burosumab revenue, sales, average price and gross margin, recent developments.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Burosumab market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.

Global Burosumab Market, By Region:

• United States
• China
• Europe
• Japan
• South Korea
• ASEAN
• India

Global Burosumab Market, Segmentation by Type

• 10mg/mL
• 20mg/mL
• 30mg/mL

Global Burosumab Market, Segmentation by Application

• Minor Patients Over 1 Year Old
• Adult Patients

Companies Profiled:

• Ultragenyx
• Kyowa Kirin

Key Questions Answered

1. How big is the global Burosumab market?

2. What is the demand of the global Burosumab market?

3. What is the year over year growth of the global Burosumab market?

4. What is the production and production value of the global Burosumab market?

5. Who are the key producers in the global Burosumab market?

6. What are the growth factors driving the market demand?

Contents

1 SUPPLY SUMMARY

1.1 Burosumab Introduction
1.2 World Burosumab Supply & Forecast
  1.2.1 World Burosumab Production Value (2017 & 2021 & 2028)
  1.2.2 World Burosumab Production (2017-2028)
  1.2.3 World Burosumab Pricing Trends (2017-2028)
1.3 World Burosumab Production by Region
  1.3.1 World Burosumab Production Value by Region (2017-2028)
  1.3.2 World Burosumab Production by Region (2017-2028)
  1.3.3 World Burosumab Average Price by Region (2017-2028)
  1.3.4 North America Burosumab Production (2017-2028)
  1.3.5 Japan Burosumab Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Burosumab Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Burosumab Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 DEMAND SUMMARY

2.1 World Burosumab Demand (2017-2028)
2.2 World Burosumab Consumption by Region
  2.2.1 World Burosumab Consumption by Region (2017-2022)
  2.2.2 World Burosumab Consumption Forecast by Region (2023-2028)
2.3 United States Burosumab Consumption (2017-2028)
2.4 China Burosumab Consumption (2017-2028)
2.5 Europe Burosumab Consumption (2017-2028)
2.6 Japan Burosumab Consumption (2017-2028)
2.7 South Korea Burosumab Consumption (2017-2028)
2.8 ASEAN Burosumab Consumption (2017-2028)
2.9 India Burosumab Consumption (2017-2028)

3 WORLD BUROSUMAB MANUFACTURERS COMPETITIVE ANALYSIS

3.1 World Burosumab Production Value by Manufacturer (2017-2022)
3.2 World Burosumab Production by Manufacturer (2017-2022)
3.3 World Burosumab Average Price by Manufacturer (2017-2022)
3.4 Burosumab Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
  3.5.1 Global Burosumab Industry Rank of Major Manufacturers
  3.5.2 Global Concentration Ratios (CR4) for Burosumab in 2021
  3.5.3 Global Concentration Ratios (CR8) for Burosumab in 2021
3.6 Burosumab Market: Overall Company Footprint Analysis
  3.6.1 Burosumab Market: Region Footprint
  3.6.2 Burosumab Market: Company Product Type Footprint
  3.6.3 Burosumab Market: Company Product Application Footprint
3.7 Competitive Environment
  3.7.1 Historical Structure of the Industry
  3.7.2 Barriers of Market Entry
  3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 UNITED STATES VS CHINA VS REST OF THE WORLD

4.1 United States VS China: Burosumab Production Value Comparison
  4.1.1 United States VS China: Burosumab Production Value Comparison (2017 & 2021 & 2028)
  4.1.2 United States VS China: Burosumab Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Burosumab Production Comparison
  4.2.1 United States VS China: Burosumab Production Comparison (2017 & 2021 & 2028)
  4.2.2 United States VS China: Burosumab Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Burosumab Consumption Comparison
  4.3.1 United States VS China: Burosumab Consumption Comparison (2017 & 2021 & 2028)
  4.3.2 United States VS China: Burosumab Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Burosumab Key Producers and Market Share, 2017-2022
  4.4.1 Major Manufacturer of Burosumab in United States, Company Headquarters and Production Place (States, Country)
  4.4.2 United States Burosumab Production Value by Domestic Manufacturer, (2017-2022)
  4.4.3 United States Burosumab Production by Domestic Manufacturer, (2017-2022)
4.5 China Burosumab Key Producers and Market Share, 2017-2022
  4.5.1 Major Manufacturer of Burosumab in China, Company Headquarters and Production Place (Province, Country)
  4.5.2 China Burosumab Production Value by Domestic Manufacturer, (2017-2022)
  4.5.3 China Burosumab Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Burosumab Key Producers and Market Share, 2017-2022
  4.6.1 Major Manufacturer of Burosumab in Rest of World, Company Headquarters and Production Place (State, Country)
  4.6.2 Rest of World Burosumab Production Value by Domestic Manufacturer, (2017-2022)
  4.6.3 Rest of World Burosumab Production by Domestic Manufacturer, (2017-2022)

5 MARKET ANALYSIS BY TYPE

5.1 World Burosumab Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
  5.2.1 10mg/mL
  5.2.2 20mg/mL
  5.2.3 30mg/mL
5.3 Market Segment by Type
  5.3.1 World Burosumab Production by Type (2017-2028)
  5.3.2 World Burosumab Production Value by Type (2017-2028)
  5.3.3 World Burosumab Average Price by Type (2017-2028)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Burosumab Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
  6.2.1 Minor Patients Over 1 Year Old
  6.2.2 Adult Patients
6.3 Market Segment by Application
  6.3.1 World Burosumab Production by Application (2017-2028)
  6.3.2 World Burosumab Production Value by Application (2017-2028)
  6.3.3 World Burosumab Average Price by Application (2017-2028)

7 COMPANY PROFILES

7.1 Ultragenyx
  7.1.1 Ultragenyx Details
  7.1.2 Ultragenyx Major Business
  7.1.3 Ultragenyx Burosumab Product and Services
  7.1.4 Ultragenyx Burosumab Production, Price, Value, Gross Margin and Market Share (2017-2022)
  7.1.5 Ultragenyx Recent Developments/Updates
  7.1.6 Ultragenyx Competitive Strengths & Weaknesses
7.2 Kyowa Kirin
  7.2.1 Kyowa Kirin Details
  7.2.2 Kyowa Kirin Major Business
  7.2.3 Kyowa Kirin Burosumab Product and Services
  7.2.4 Kyowa Kirin Burosumab Production, Price, Value, Gross Margin and Market Share (2017-2022)
  7.2.5 Kyowa Kirin Recent Developments/Updates
  7.2.6 Kyowa Kirin Competitive Strengths & Weaknesses

8 RAW MATERIAL AND INDUSTRY CHAIN

8.1 Raw Material of Burosumab and Key Manufacturers
8.2 Burosumab Manufacturing Costs
8.3 Burosumab Production Process
8.4 Burosumab Industrial Chain

9 DISTRIBUTION CHANNEL ANALYSIS

9.1 Distribution Channel Breakdown for Burosumab Shipments (%): 2017-2028
  9.1.1 Direct Channel
  9.1.2 Indirect Channel
9.2 Burosumab Typical Distributors
9.3 Burosumab Typical Customers

10 RESEARCH FINDINGS AND CONCLUSION

11 APPENDIX

11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. World Burosumab Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Burosumab Production Value by Region (2017-2022) & (USD Million)
Table 3. World Burosumab Production Value by Region (2023-2028) & (USD Million)
Table 4. World Burosumab Production Value Market Share by Region (2017-2022)
Table 5. World Burosumab Production Value Market Share by Region (2023-2028)
Table 6. World Burosumab Production by Region (2017-2022) & (K Units)
Table 7. World Burosumab Production by Region (2023-2028) & (K Units)
Table 8. World Burosumab Production Market Share by Region (2017-2022)
Table 9. World Burosumab Production Market Share by Region (2023-2028)
Table 10. World Burosumab Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Burosumab Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Burosumab Major Market Trends
Table 13. World Burosumab Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Burosumab Consumption by Region (2017-2022) & (K Units)
Table 15. World Burosumab Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Burosumab Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Burosumab Producers in 2021
Table 18. World Burosumab Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Burosumab Producers in 2021
Table 20. World Burosumab Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Burosumab Company Evaluation Quadrant
Table 22. World Burosumab Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Burosumab Production Site of Key Manufacturer
Table 24. Burosumab Market: Company Product Type Footprint
Table 25. Burosumab Market: Company Product Application Footprint
Table 26. Burosumab Competitive Factors
Table 27. Burosumab New Entrant and Capacity Expansion Plans
Table 28. Burosumab Mergers & Acquisitions Activity
Table 29. United States VS China Burosumab Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Burosumab Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Burosumab Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Burosumab in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Burosumab Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Burosumab Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Burosumab Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Burosumab Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Burosumab in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Burosumab Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Burosumab Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Burosumab Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Burosumab Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Burosumab in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Burosumab Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Burosumab Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Burosumab Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Burosumab Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Burosumab Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Burosumab Production by Type (2017-2022) & (K Units)
Table 49. World Burosumab Production by Type (2023-2028) & (K Units)
Table 50. World Burosumab Production Value by Type (2017-2022) & (USD Million)
Table 51. World Burosumab Production Value by Type (2023-2028) & (USD Million)
Table 52. World Burosumab Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Burosumab Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Burosumab Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Burosumab Production by Application (2017-2022) & (K Units)
Table 56. World Burosumab Production by Application (2023-2028) & (K Units)
Table 57. World Burosumab Production Value by Application (2017-2022) & (USD Million)
Table 58. World Burosumab Production Value by Application (2023-2028) & (USD Million)
Table 59. World Burosumab Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Burosumab Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Ultragenyx Basic Information, Manufacturing Base and Competitors
Table 62. Ultragenyx Major Business
Table 63. Ultragenyx Burosumab Product and Services
Table 64. Ultragenyx Burosumab Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Ultragenyx Recent Developments/Updates
Table 66. Kyowa Kirin Basic Information, Manufacturing Base and Competitors
Table 67. Kyowa Kirin Major Business
Table 68. Kyowa Kirin Burosumab Product and Services
Table 69. Kyowa Kirin Burosumab Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 70. Burosumab Raw Material
Table 71. Key Manufacturers of Burosumab Raw Materials
Table 72. Burosumab Typical Distributors
Table 73. Burosumab Typical Customers

List Of Figures

LIST OF FIGURES

Figure 1. Burosumab Picture
Figure 2. World Burosumab Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Burosumab Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Burosumab Production (2017-2028) & (K Units)
Figure 5. World Burosumab Average Price (2017-2028) & (US$/Unit)
Figure 6. World Burosumab Production Value Market Share by Region (2017-2028)
Figure 7. World Burosumab Production Market Share by Region (2017-2028)
Figure 8. North America Burosumab Production (2017-2028) & (K Units)
Figure 9. Japan Burosumab Production (2017-2028) & (K Units)
Figure 10. Burosumab Market Drivers
Figure 11. Factors Affecting Demand
Figure 12. World Burosumab Demand (2017-2028) & (K Units)
Figure 13. World Burosumab Consumption Market Share by Region (2017-2028)
Figure 14. United States Burosumab Consumption (2017-2028) & (K Units)
Figure 15. China Burosumab Consumption (2017-2028) & (K Units)
Figure 16. Europe Burosumab Consumption (2017-2028) & (K Units)
Figure 17. Japan Burosumab Consumption (2017-2028) & (K Units)
Figure 18. South Korea Burosumab Consumption (2017-2028) & (K Units)
Figure 19. ASEAN Burosumab Consumption (2017-2028) & (K Units)
Figure 20. India Burosumab Consumption (2017-2028) & (K Units)
Figure 21. Producer Shipments of Burosumab by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 22. Global Four-firm Concentration Ratios (CR4) for Burosumab Markets in 2021
Figure 23. Global Four-firm Concentration Ratios (CR8) for Burosumab Markets in 2021
Figure 24. United States VS China: Burosumab Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 25. United States VS China: Burosumab Production Market Share Comparison (2017 & 2021 & 2028)
Figure 26. United States VS China: Burosumab Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 27. Key Producers and Market Share of Burosumab in United States
Figure 28. Key Producers and Market Share of Burosumab in China
Figure 29. Key Producers and Market Share of Burosumab in Rest of World
Figure 30. World Burosumab Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 31. World Burosumab Production Value Market Share by Type in 2021
Figure 32. 10mg/mL
Figure 33. 20mg/mL
Figure 34. 30mg/mL
Figure 35. World Burosumab Production Market Share by Type (2017-2028)
Figure 36. World Burosumab Production Value Market Share by Type (2017-2028)
Figure 37. World Burosumab Average Price by Type (2017-2028) & (US$/Unit)
Figure 38. World Burosumab Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 39. World Burosumab Production Value Market Share by Application in 2021
Figure 40. Minor Patients Over 1 Year Old
Figure 41. Adult Patients
Figure 42. World Burosumab Production Market Share by Application (2017-2028)
Figure 43. World Burosumab Production Value Market Share by Application (2017-2028)
Figure 44. World Burosumab Average Price by Application (2017-2028) & (US$/Unit)
Figure 45. Manufacturing Cost Structure Analysis of Burosumab in 2021
Figure 46. Manufacturing Process Analysis of Burosumab
Figure 47. Burosumab Industrial Chain
Figure 48. Distribution Channel Breakdown for Burosumab Shipments (%): 2017-2028
Figure 49. Direct Channel Pros & Cons
Figure 50. Indirect Channel Pros & Cons
Figure 51. Methodology
Figure 52. Research Process and Data Source